Efficacy and safety of ustekinumab in Behçet disease: Results from the prospective phase 2 STELABEC trial.
Auteurs : London J, Régent A, Dion J, Jilet L, Jachiet M, Lidove O, Cohen-Aubart F, Aractingi S, Guégan S, Pennaforte JL, Abdoul H, Puéchal X, Terrier B.
